TTK Healthcare closes trading window from July 1, 2026

0 min read     Updated on 23 Jun 2026, 01:54 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

TTK Healthcare closed its trading window for designated persons effective July 1, 2026, to comply with SEBI regulations. The window will reopen 48 hours after the unaudited financial results for the quarter ending June 30, 2026, are declared. The board meeting date for result approval will be notified later.

powered bylight_fuzz_icon
43679045

*this image is generated using AI for illustrative purposes only.

TTK Healthcare has closed its trading window for designated persons and their immediate relatives effective July 1, 2026. The closure is pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct for Prevention of Insider Trading. The window will remain shut until 48 hours after the declaration of the unaudited financial results for the first quarter ending June 30, 2026.

The company has informed all designated persons and their immediate relatives not to trade in the company's securities during this period. The restriction is a standard compliance measure to prevent insider trading during the sensitive period preceding financial results announcements.

The specific date for the board meeting to consider and approve the unaudited financial results for Q1FY27 will be intimated in due course. The filing was submitted to BSE Limited and National Stock Exchange of India Limited on June 22, 2026.

Event Date
Trading Window Closure July 01, 2026
Trading Window Reopening 48 hours after Q1FY27 results declaration
Quarter End June 30, 2026
Filing Date June 22, 2026

Historical Stock Returns for TTK Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.97%+4.83%+3.50%-11.82%-27.47%+43.25%

How might the closure of the trading window impact liquidity in TTK Healthcare's stock ahead of the Q1FY27 results?

What are analysts' expectations for TTK Healthcare's Q1FY27 performance, and could the early window closure signal significant deviations?

Will the closure of the trading window influence investor sentiment or trading volumes in the secondary market?

TTK Prestige declares no encumbrance on TTK Healthcare shares in FY26

0 min read     Updated on 18 Jun 2026, 04:36 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

TTK Prestige filed a declaration under SEBI regulations confirming no encumbrance on its 1,440 equity shares in TTK Healthcare for FY 2025-26.

powered bylight_fuzz_icon
43224927

*this image is generated using AI for illustrative purposes only.

TTK Prestige has submitted a declaration to the stock exchanges confirming that it did not create any encumbrance on its shareholding in TTK Healthcare Limited during the financial year 2025-26. The disclosure was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Declaration Details

The company specified that the declaration covers its entire holding period for the financial year. The communication was addressed to BSE Limited, National Stock Exchange of India Limited, and the Audit Committee of TTK Healthcare Limited.

Parameter Details
Target Company TTK Healthcare Limited
BSE Scrip Code 507747
NSE Scrip Code TTKHLTCARE
Shares Held 1,440 Equity Shares of Rs.10/- each
Encumbrance Status No encumbrance made directly or indirectly
Financial Year 2025-26

The filing was signed by Manjula K V, Company Secretary & Compliance Officer of TTK Prestige Limited.

Historical Stock Returns for TTK Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.97%+4.83%+3.50%-11.82%-27.47%+43.25%

Does this clean status signal a potential strategic shift in TTK Prestige's holding of TTK Healthcare shares?

Could this unencumbered position facilitate a future divestment or increase in stake in TTK Healthcare?

How might this disclosure impact TTK Prestige's ability to leverage these shares for future corporate financing?

More News on TTK Healthcare

1 Year Returns:-27.47%